Drug Discovery World
In this Application Note, Charles River discusses the need for more preclinical animal models that recapitulate disease progression in order to develop new therapies for progressive multiple sclerosis.
Media Coverage
The Need for More Translational Preclinical Models of Multiple Sclerosis
